A Stanford-led team developed a machine-learning model that helps predict the time between life support removal and organ viability in donors. By improving timing and selection for liver transplants, this tool could reduce costs and increase successful graft outcomes, addressing a major challenge in transplant medicine.

Researchers at Clínic-IDIBAPS published an important scientific review summarizing advances in our understanding of liver sinusoidal endothelial cells — specialized cells lining small blood vessels in the liver that play key roles in inflammation, fibrosis, and immune regulation. These insights could help unlock new therapeutic strategies for chronic liver diseases.

A multicenter clinical trial led by UC Davis Health found that a novel monoclonal antibody, nebokitug, was safe and showed potential effectiveness in patients with primary sclerosing cholangitis (PSC), a rare but progressive liver disease. Early results suggest reduced inflammation and fibrosis, offering hope for a condition with limited treatment options.